Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
September 30 2019 - 8:30AM
Business Wire
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine
company, announced today that members of the management team will
present at the following investor and industry conferences in
October:
Cell & Gene Meeting on the Mesa
2019 Corporate presentation Wednesday, Oct 2nd at 3:15 p.m.
Pacific Time Location: Carlsbad, CA
Panel: What does the future hold for gene
editing? Friday, Oct 4th at 9:45 a.m. Pacific Time Location:
Carlsbad, CA
Cantor Global Healthcare Conference
2019 Friday, Oct 4th at 11:15 a.m. Eastern Time Location: New
York, NY
Chardan 3rd Annual Genetic Medicines
Conference Monday, Oct 7th at 8:30 a.m. Eastern Time Location:
New York, NY
Jefferies Gene Therapy/Editing Summit
Tuesday, Oct 8th at 11:15 a.m. Eastern Time Location: New York,
NY
Presentations will be webcast live and may be accessed via a
link on the Sangamo Therapeutics website in the Investors and Media
section under Events and Presentations. The presentations will also
be available on the Sangamo website after the event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking
science into genomic medicines with the potential to transform
patients’ lives using gene therapy, ex vivo gene-edited cell
therapy, and in vivo genome editing and gene regulation. For more
information about Sangamo, visit www.sangamo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190930005267/en/
Investor Relations – Global McDavid
Stilwell 510-970-6000, x219 mstilwell@sangamo.com
Media Inquiries – Global Aron
Feingold 510-970-6000, x421 afeingold@sangamo.com
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Sep 2023 to Sep 2024